Applying Pharmacogenetics to Warfarin Dosing in Chinese Patients

Clinical trial NCT01610141 · UNKNOWN

Trial details

NCT number: NCT01610141
Sponsor: Chinese PLA General Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Atrial Fibrillation Deep Vein Thrombosis Pulmonary Embolism Heart Valve Disease

Start date: 2012-06-01
Primary completion: 2014-06-01
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.